Phase I-II study of the somatostatin analogue lanreotide in hormone-refractory prostate cancer (Q44206837)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 1995
edit
Language Label Description Also known as
English
Phase I-II study of the somatostatin analogue lanreotide in hormone-refractory prostate cancer
scientific article published in January 1995

    Statements

    Phase I-II study of the somatostatin analogue lanreotide in hormone-refractory prostate cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit